rs559836164
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_014625.4(NPHS2):c.124G>A(p.Gly42Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000596 in 1,516,052 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_014625.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPHS2 | NM_014625.4 | c.124G>A | p.Gly42Arg | missense_variant | 1/8 | ENST00000367615.9 | NP_055440.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPHS2 | ENST00000367615.9 | c.124G>A | p.Gly42Arg | missense_variant | 1/8 | 1 | NM_014625.4 | ENSP00000356587 | P1 | |
NPHS2 | ENST00000367616.4 | c.124G>A | p.Gly42Arg | missense_variant | 1/7 | 1 | ENSP00000356588 |
Frequencies
GnomAD3 genomes AF: 0.00343 AC: 521AN: 152050Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.000794 AC: 90AN: 113346Hom.: 1 AF XY: 0.000633 AC XY: 40AN XY: 63148
GnomAD4 exome AF: 0.000280 AC: 382AN: 1363896Hom.: 2 Cov.: 31 AF XY: 0.000254 AC XY: 171AN XY: 673002
GnomAD4 genome AF: 0.00342 AC: 521AN: 152156Hom.: 4 Cov.: 32 AF XY: 0.00296 AC XY: 220AN XY: 74386
ClinVar
Submissions by phenotype
Nephrotic syndrome, type 2 Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Counsyl | Feb 17, 2017 | - - |
Steroid-resistant nephrotic syndrome Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 03, 2020 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at